Enhanced potency of human calcitonin when fibrillation is avoided.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Pharmacy and Science

• Publication date

  1995-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/JPS.2600840610PMID 7562410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The structure and mechanism of formation of human calcitonin fibrils.

  1993cited by this paper
• SCAN, an exploratory program for preliminary analysis of bioassay and immunoassay data.

  1985cited by this paper
• Calcitonin alters behaviour of isolated osteoclasts

  1982cited by this paper
• Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance.

  1980cited by this paper
• Comparison of human, porcine and salmon synthetic calcitonins in man and in the rat.

  1971cited by this paper

• Both single mutation and molecular conjugation on the mutant prevent calcitonin from forming amyloid fibrils.

  2025cites this paper
• Unraveling the aggregation mechanism and bioactivity of Tyr12 nitrated human calcitonin.

  2025cites this paper
• Computational insights into the aggregation mechanism of human calcitonin.

  2025cites this paper
• Peroxynitrite scavenger FeTPPS binds with hCT to effectively inhibit its amyloid aggregation.

  2024cites this paper
• Molecular Insights into the Effects of F16L and F19L Substitutions on the Conformation and Aggregation Dynamics of Human Calcitonin

  2024cites this paper
• Unveiling the Inhibitory Effect of Magnolol in the Aggregation of Human Calcitonin (hCT): A Comprehensive In-Silico Study.

  2024cites this paper
• Unraveling the underlying mechanisms of reduced amyloidogenic properties in human calcitonin via double mutations

  2024cites this paper
• Deciphering the influence of Y12L and N17H substitutions on the conformation and oligomerization of human calcitonin.

  2024cites this paper
• Synthesis of Fe3O4-Chlorophyllin Nanoparticles for Preventing Amyloid Formation by Human Calcitonin

  2023cites this paper
• Investigating the inhibitory property of DM hCT on hCT fibrillization via its relevant peptide fragments

  2023cites this paper
• Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants

  2022cites this paper
• Expanding peptide-cucurbit[7]uril interactions through selective N-terminal reductive alkylation

  2021cites this paper
• Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations.

  2021cites this paper
• Flavonoids with Vicinal Hydroxyl Groups Inhibit Human Calcitonin Amyloid Formation.

  2020cites this paper
• Design and Characterizations of Inhalable Poly(lactic-co-glycolic acid) Microspheres Prepared by the Fine Droplet Drying Process for a Sustained Effect of Salmon Calcitonin

  2020cites this paper
• Investigation of the stability and the helix-tail interaction of sCT and its various charged mutants based on comparative molecular dynamics simulations

  2020cites this paper
• Fibrillation of Human Calcitonin and its Analogs: Effects of Phosphorylation and Disulfide Reduction.

  2020cites this paper
• Y12 nitration of human calcitonin (hCT): A promising strategy to produce non-aggregation bioactive hCT.

  2020cites this paper
• Biology of Calcitonin as An Osteoprotective Agent

  2020cites this paper
• Heme prevents highly amyloidogenic human calcitonin (hCT) aggregation: A potential new strategy for the clinical reuse of hCT.

  2019cites this paper
• Development and characterization of supramolecular calcitonin assembly and assessment of its interactions with the bone remodelling process.

  2019cites this paper
• Inhibiting Human Calcitonin Fibril Formation with its Most Relevant Aggregation-Resistant Analog.

  2019cites this paper
• Fibril Nucleation Kinetics of a Pharmaceutical Peptide: The Role of Conformation Stability, Formulation Factors, and Temperature Effect.

  2018cites this paper
• Structural Biology of Calcitonin: From Aqueous Therapeutic Properties to Amyloid Aggregation

  2017cites this paper
• The effect of formulation variables on protein stability and integrity of a model IgG4 monoclonal antibody and translation to formulation of a model ScFv

  2017cites this paper
• Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time

  2017cites this paper
• How Glycosaminoglycans Promote Fibrillation of Salmon Calcitonin*

  2016cites this paper
• Acylation of Therapeutic Peptides: Interaction with Lipid Membranes and its Implications in Oral Delivery

  2016cites this paper
• Salmon calcitonin: conformational changes and stabilizer effects

  2015cites this paper
• Mild hyperthermia influence on Herceptin® properties

  2015cites this paper
• Inhibitory effects of magnolol and honokiol on human calcitonin aggregation

  2015cites this paper
• Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement.

  2015cites this paper
• Theory and practice of size exclusion chromatography for the analysis of protein aggregates.

  2014cites this paper
• Structural Elements Regulating Interactions in the Early Stages of Fibrillogenesis: A Human Calcitonin Model System

  2012cites this paper
• Enhanced physical stability of human calcitonin after methionine oxidation.

  2011cites this paper
• Transdermal Delivery of Peptides and Proteins

  2011cites this paper
• Bioactivity Determination of Native and Variant Forms of Therapeutic Interferons

  2011cites this paper
• Sonophoresis for Intradermal and Transdermal Drug Delivery

  2011cites this paper
• Characterization of protein aggregates following a heating and freezing process

  2011cites this paper
• Study of aggregation, denaturation and reduction of interferon alpha-2 products by size-exclusion high-performance liquid chromatography with fluorescence detection and biological assays.

  2010cites this paper
• Converting the Highly Amyloidogenic Human Calcitonin into a Powerful Fibril Inhibitor by Three-dimensional Structure Homology with a Non-amyloidogenic Analogue*

  2010cites this paper
• New methods allowing the detection of protein aggregates

  2009cites this paper
• A High Throughput Protein Formulation Platform: Case Study of Salmon Calcitonin

  2008cites this paper
• Chapter 7 A New Class of Peptide-Forming Channel: Calcitonins

  2008cites this paper
• Prediction of aggregation-prone regions in structured proteins.

  2008cites this paper
• High throughput screening of protein formulation stability: practical considerations.

  2007cites this paper
• Acetyl-[Asn30,Tyr32]-calcitonin fragment 8-32 forms channels in phospholipid planar lipid membranes

  2007cites this paper
• Detection and characterization of protein aggregates by fluorescence microscopy.

  2007cites this paper
• Quantitative and reliable in vitro method combining scanning electron microscopy and image analysis for the screening of osteotropic modulators

  2006cites this paper
• Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin.

  2005cites this paper
• Early stages of salmon calcitonin aggregation: effect induced by ageing and oxidation processes in water and in the presence of model membranes.

  2005cites this paper
• Pharmaceutical liquid crystals: the relevance of partially ordered systems.

  2005cites this paper
• Biodegradable multiblock copolymers for drug delivery applications

  2004cites this paper
• Modulating Calcitonin Fibrillogenesis

  2004cites this paper
• Calcium-deficient apatite: a first in vivo study concerning bone ingrowth.

  2003cites this paper
• Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS.

  2002cites this paper
• Molecular and Clinical Pharmacology of Calcitonin

  2002cites this paper
• Stability aspects of salmon calcitonin entrapped in poly(ether-ester) sustained release systems.

  2002cites this paper
• Effect of elcatonin on osteoinduction by recombinant human bone morphogenetic protein-2.

  2000cites this paper
• In vitro metabolism of human and salmon calcitonins in rat liver and kidney evaluated by liquid chromatography-tandem mass spectrometry

  2000cites this paper
• Solution stability of salmon calcitonin at high concentration for delivery in an implantable system.

  2000cites this paper
• Degradation and Aggregation of Human Calcitonin In Vitro

  1999cites this paper
• Production of biologically active salmon calcitonin in the milk of transgenic rabbits

  1998cites this paper
• A role for the C-terminus of calcitonin in aggregation and gel formation: a comparative study of C-terminal fragments of human and salmon calcitonin.

  1998cites this paper
• 1 1 The effect of formulation variables on protein stability and integrity of a model IgG 4 monoclonal 2 antibody and translation to formulation of a model ScFv 3 4

  year unknowncites this paper